Evidence map›Paper›PMID 36417857›Full record

ArticleCell reports2022

Interferon partly dictates a divergent transcriptional response in poxvirus-infected and bystander inflammatory monocytes.

Carolina R Melo-Silva, Marisa I Roman, Cory J Knudson, Lingjuan Tang, Ren-Huan Xu, Michel Tassetto, Patrick Dolan, Raul Andino, Luis J Sigal

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Carolina R Melo-SilvaDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Marisa I RomanDepartment of Physics, St. Joseph University, Philadelphia PA 19131, USA.
Cory J KnudsonDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA; GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, PA 19426, USA.
Lingjuan TangDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Ren-Huan XuAdvanced RNA Vaccine Technologies, Inc., 12358 Parklawn Dr, North Bethesda, MD 20852, USA.
Michel TassettoDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94158, USA.
Patrick DolanDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94158, USA; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 20892-3210, USA.
Raul AndinoDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94158, USA.
Luis J SigalDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA. Electronic address: luis.sigal@jefferson.edu.
Thomas Jefferson University · USUniversity of California, San Francisco · USNational Institutes of Health · USSaint Joseph's University · US

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI Andrew Chapman · 1995 to 2026
$94.8M
Mapping spatiotemporal dynamics during enterovirus infection across cells and tissuesR01AI169460 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Raul Andino, Luis J Sigal · 2022 to 2026
$4.5M
Inflammatory monocytes in the draining lymph node of ECTV infected miceR01AI110457 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SIGAL, LUIS J · 2015 to 2019
$2.3M
Training grant on Vaccines and Immunotherapies for Infectious Diseases and CancerT32AI134646 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SCHNELL, MATTHIAS JOHANNES, SIGAL, LUIS J · 2018 to 2022
$1.1M
The Immune Response to Ectromelia Virus in the Draining Lymph NodeR56AI110457 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SIGAL, LUIS J · 2014 to 2021
$1.0M
NCI NIH HHS P30 CA056036NIAID NIH HHS R01 AI110457NIAID NIH HHS R01 AI169460NIAID NIH HHS R56 AI110457NIAID NIH HHS T32 AI134646
6 · The paper itself

Abstract

Inflammatory monocytes (iMOs) and B cells are the main targets of the poxvirus ectromelia virus (ECTV) in the lymph nodes of mice and play distinct roles in surviving the infection. Infected and bystander iMOs control ECTV's systemic spread, preventing early death, while B cells make antibodies that eliminate ECTV. Our work demonstrates that within an infected animal that survives ECTV infection, intrinsic and bystander infection of iMOs and B cells differentially control the transcription of genes important for immune cell function and, perhaps, cell identity. Bystander cells upregulate metabolism, antigen presentation, and interferon-stimulated genes. Infected cells downregulate many cell-type-specific genes and upregulate transcripts typical of non-immune cells. Bystander (Bys) and infected (Inf) iMOs non-redundantly contribute to the cytokine milieu and the interferon response. Furthermore, we uncover how type I interferon (IFN-I) or IFN-γ signaling differentially regulates immune pathways in Inf and Bys iMOs and that, at steady state, IFN-I primes iMOs for rapid IFN-I production and antigen presentation.

Indexed as

Ectromelia, InfectiousEctromelia virusInterferon Type IPoxviridaeAnimalsAntiviral AgentsMiceMonocytesAntiviral AgentsInterferon Type Ibystander and intrinsic infectioncellular response to infectionCP: Immunologyectromelia virusinflammatory monocytesinterferonspoxvirustranscriptomicsviral immunology

Identifiers

PMID36417857
PMCPMC9798443
OpenAlexW4309593303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.